2026-08-27 · Peppu
The Future Arrived On A Payment Plan
The Prophecy Nobody Checks
When people grade science fiction on its predictions, they grade the props. Did we get the flying cars, the chrome limbs, the neural jacks, the holograms. By that scoring system cyberpunk failed badly, and the genre gets treated as a beautiful aesthetic that turned out to be mostly wrong about the future.
But the props were never the prediction. They were set dressing on a much sharper claim, and the claim was social rather than technological. Cyberpunk's actual thesis was that enhancement would arrive as a product before it arrived as a right. That it would be sold, priced, and distributed by whoever owned it. That the people who could pay would improve first and pull away from everyone else. And that wherever the official price was too high, a gray channel would open underneath it, staffed by people operating outside the sanctioned system.
Nobody grades that prediction, because it does not look like a prop. It looks like the news. And on that scoring system, the genre was not wrong at all. It was so precisely right that we stopped noticing, the way you stop noticing weather.
They Got The Class Line Right
Every meaningful enhancement in modern history has debuted as a luxury good. Not because of villainy, but because that is simply what the economics of a new molecule look like. Development is enormously expensive, the patent window is finite, and the rational move for whoever holds it is to price against the people who can pay most. The first buyers of any upgrade are always the people who least needed the edge.
You can watch this happening right now with the appetite drugs that rewrote an entire culture's relationship with food in under a decade. At launch, in most markets, the monthly cost sat well outside what an ordinary person could sustain, and access sorted itself along income lines almost perfectly. Around it grew an entire adjacent economy of longevity clinics, executive physicals, and concierge medicine, all selling essentially the same proposition: better maintenance, faster access, for people who can pay for both.
That is the cyberpunk class line, arriving exactly on schedule, just without the neon. It did not need corporate arcologies or private armies. It only needed a price tag and the ordinary functioning of a market, which is a much more boring mechanism than any novelist would have chosen and considerably more effective than the ones they invented.
The Gray Channel Opens On Its Own
The second prediction follows from the first with something close to physical inevitability. Put a large enough gap between what something costs and what people are willing to pay, and a channel opens underneath it. This is not a moral claim and it does not require anyone to be a criminal. It is just what pressure differentials do.
So the fictional back-alley operator turns out to have been a sociological forecast rather than a character design. In the real version there is no neon sign and no chrome surgery table. There are compounding operations, overseas manufacturers, forums where people trade notes with more rigor than you might expect and less than the subject deserves, and an entire category of material moving under the phrase research use only, which is a real legal boundary and also, frequently, a doorway everyone can see.
It is worth being clear eyed rather than romantic about what that means. A gray channel routes around price, but it also routes around the machinery that verifies what you are actually holding. That machinery is expensive and slow for reasons that are not all bureaucratic. Purity varies. Identity varies. This is precisely why third party analysis is not paperwork or marketing but the actual substance of the transaction, and why anyone operating in this space who cannot show you what is in the vial is asking you to accept the risk that the official system exists to remove. The frontier is real. So is the reason the guardrails were built.
What Chrome Could Never Do
Here is where the prophecy breaks, and it breaks in our favor for a reason the genre never anticipated. Cyberpunk assumed the upgrade would be hardware, and hardware has miserable economics for the person who wants it cheap. A mechanical limb has to be manufactured as a physical object, fitted to one specific body, implanted by a surgeon, and serviced forever. Every unit costs real money to make. Nothing about that gets dramatically cheaper just because time passes, which is why the genre could plausibly imagine a permanent divide between the augmented and everyone else.
Molecules do not work like that. A molecule is information first and matter second. Once a synthesis route is known, manufacturing scales in a way physical devices never will, and the marginal cost of the thousandth unit bears almost no relationship to the cost of discovering the first. There is no fitting. There is no surgeon. There is no service contract. The expensive part was the knowing, and knowing is the one category of thing that gets cheaper every year rather than more expensive.
This is the quiet reason biological enhancement is far more democratic in the long run than any implant could have been. The genre's dystopia required the upgrade to stay scarce. Chemistry does not permit that for very long.
The Twenty Year Rule
History is fairly consistent about the shape of this. Statins entered the world in the late nineteen eighties as a serious expense and now cost pennies, taken by an enormous fraction of the aging population without anyone considering it exotic. The antiretrovirals that made HIV survivable ran to many thousands of dollars a year when they arrived, and generic manufacturing eventually brought the same regimens down to a small fraction of that, which is one of the largest humanitarian shifts of the last half century and happened almost entirely through patent expiry and manufacturing scale. Sildenafil launched as an expensive branded product and became a commodity so cheap it is now a punchline.
The pattern is the same every time. Luxury, then normal, then trivial, then invisible. What changes is only the clock speed, and the clock has been getting faster as manufacturing capacity spreads across more of the world and more actors are positioned to produce a compound the moment they legally can.
Which means the correct way to read the current moment is not as a permanent stratification. It is as the expensive phase of a curve that has bent downward every previous time it has been run. The people paying enormous sums today for access to what is new are, functionally, subsidizing the phase that makes it ordinary. That is an unglamorous role and it is also how essentially every valuable thing in medicine has reached the people who needed it most.
The Divide Is Not Money
So if price eventually collapses, and access eventually broadens, what actually separates people? Here is the uncomfortable answer, and it is the reason this journal exists at all. When everything is cheap and everything is available, the scarce resource stops being money and becomes discernment.
We are already living in the early version of this. The bottleneck for most people is not that they cannot obtain things. It is that the information environment around those things is almost perfectly optimized to prevent clear thinking. Confident claims outperform careful ones. A dramatic mouse study spreads a thousand times further than the human trial that failed to replicate it. Every incentive in the content economy rewards certainty and punishes the accurate answer, which is very often that we do not know yet.
That is the real divide forming. Not between people who can afford the upgrade and people who cannot, because that gap closes on a schedule history has already demonstrated. It is between people who can tell the difference between evidence and enthusiasm and people who cannot, and that gap does not close on its own. It has to be closed deliberately, one person at a time, by choosing sources that are willing to tell you the boring version.
Who Gets To Be Early
Being early is not the same as being right, and the culture around this subject constantly confuses the two. Early means you are operating where the evidence is thin, the confidence is loud, and the correction has not arrived yet. Sometimes that is where the enormous advantages are. Sometimes it is where the people who got hurt are, and you only find out which one you were in retrospect.
The genre understood the glamour of that position and not much else about it. Its enhanced characters were cool. They were rarely depicted reading a certificate of analysis, or waiting eighteen months for a replication, or concluding that a promising thing was not promising enough to justify being the experiment. Those are the actual skills of the frontier, and they are profoundly uncinematic, which is exactly why fiction never bothered to teach them.
So the future did arrive, and it arrived on a payment plan, priced high and distributed unevenly, exactly as predicted. What was not predicted is that the payment plan has an end date, and that when it finishes the thing that will separate people is not their balance but their judgment. That part is available now, it costs nothing, and almost nobody is buying it. Read on.
Peppu supplies analytical-grade peptide reference materials, each batch third-party verified with a Certificate of Analysis. For laboratory research use only.
Free to apply. Approved affiliates earn 30 percent direct commission plus a 5 percent approved downline cut, reviewed every 45 days for cash or crypto payout. Application only.